FDA Updates ‘Purple Book’ Database
After Recently Transitioning Biologics Lists To Online Data
The US FDA’s ‘Purple Book’ which was created “to improve transparency and functionality for stakeholders by providing a complete view of biological product options” has been updated after being recently transitioned into an online database.
